Clinical Trials on Antiphospholipid Syndrome: What is Being Done and What is Needed?

Barbui T. , Cortelazzo S. , Galli M. et al. Antiphospholipid antibodies in early repeated abortions: a case-controlled study. Fertil Steril 1988; 50: 589-92.

Creagh MD , Malia RG , Cooper SM , Smith AR , Duncan Slb , Greaves M. Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss. J Clin Pathot 1991; 44: 45-7.

Ramsey-Goldman R, Kutzer JE , Kuller LH , Guzick D. , Betts Carpenter A. , Medsger TA Jr. Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus . Am J Epidemiol 1993; 138:1057-69.

Infante-Rivard C. , David M. , Gauthier R. , Rivard GE Lupus anticoagulant, anticardiolipin antibodies and fetal loss. A case-control study. New Engl J Med 1991; 325: 1063-6.

Ginsberg JS , Brill-Edwards P. , Johnston M. et al. Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study. Blood 1992; 80: 975-80.

Alarcon-Segovia D. , Deleze M. , Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus . Medicine 1989; 68: 353-65.

Harris EN , Chan Jkh , Asherson RA , Aber VR , Gharavi AE , Hughes Grv. Thrombosis, recurrent fetal loss and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153-6.

Lockwood CJ , Romero R. , Feinberg RF , Clyne LP , Coster B. , Hobbins JC The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989 ; 161: 369-73.

Pattison NS , Chamley LW , McKay EJ , Ligging GC , Butler WS Antiphospholipid antibodies in pregnancy: prevalence and clinical associations . Br J Obstet Gynecol 1993; 100: 909-13.

Lynch A. , Marlar R. , Murphy J. et al. Antiphospholipid antibodies in predicting adverse pregnancy outcome. A prospective study. Ann Intern Med 1994; 120: 470-6.

Out HJ , Bruinse HW , Christiaens Gcml et al. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992; 167: 26-32.

Lockshin MD , Druzin ML , Goei S. et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus . New Engl J Med 1985; 313: 152-6.

Englert HJ , Derue GM , Loizou S. et al. Pregnancy and lupus: prognostic indicators and response to treatment . Q J Med 1988; 66: 125-36.

Lubbe WF , Palmer SJ , Butler WS , Liggins GC Fetal survival after prednisone suppression of maternal lupus anticoagulant . Lancet 1983; i: 1361,

Branch DW , Scott JR , Kochenour NK , Hershgold E. Obstetric complications associated with lupus anticoagulant. New Engl J Med 1985; 313: 1322-6.

Rosove MH , Tabsh K. , Wasserstrum N. , Howard P. , Hahn BH , Kalunian KC Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990; 75: 630-4.

Silveira LH , Hubble CL , Jara LJ et al. Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin . Am J Med 1992; 93: 403-11.

Lockshin MD , Druzin ML , Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibodies. Am J Obstet Gynecol 1989 ; 160: 439-43.

Cowchock FS , Reece EA , Balaban D. , Branch DW , Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992; 166: 1318-23.

Silver RK , MacGregor SN , Sholl JS , Hobart JM , Neerhof MG , Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993; 169: 1411-17.

The Antiphospholipid Antibodies in Stroke Study Group (APASS). Clinical, radiological, and pathological aspects of cerebrovascular disease associated with antiphospholipid antibodies . Stroke 1993; 24 (Suppl. I): I-120-I-123.

Barbui T. , Finazzi G. , Cortelazzo S. , Galli M. , Camerlingo M. A case-control estimate of the relative risk of cerebral ischemic disease in young subjects with antiphospholipid antibodies. Thromb Haemost 1989; 62: 584.

Long AA , Ginsberg JS , Brill-Edwards P. et al. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus. Thromb Haemost 1991; 66: 520-4.

Ginsberg KS , Liang MH , Newcomber L. et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992; 117: 997-1002.

Ordi J. , Selva A. , Monegal F. , Porcel JM , Martinez-Costa X. , Vilardell M. Anticardiolipin antibodies and dependence of a serum cofactor. A mechanism of thrombosis. J Rheumatol 1993 ; 20: 1321-4.

Galli M. , Comfurius P. , Maassen P. et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990 ; 335: 1544-7.

Levine SR , Brey RL , Joseph Clm , Havstad S. on behalf of the APASS. Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies. Stroke 1992 ; 23 (Suppl. I): 1-29-1-32.

Vianna JL , Khamashta MA , Ordi-Ros J. et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994; 96: 3-9.

Italian Registry of Antiphospholipid Antibodies (IR-APA). Thrombosis and thrombocytopenia in antiphospholipid syndrome (idiopathic and secondary to SLE): first report from the Italian Registry. Haematological 1993; 78: 313-18.

Hamsten A. , Bjorkholm M. , Norberg R. , deFaire U. , Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular event. Lancet 1986; i: 113-16.

Sltenes KE , Smith P. , Abedlnoor M. , Arnesen H. , Wisloff F. Antiphospholipid antibodies after myocardial infarction and their relation to morality, reinfarction and non-haemorrhagic stroke. Lancet 1992; 339: 451-3.

Phadke KV , Phillips RA , Clarke Dtr , Jones M. , Naish P. , Carson P. Anticardiolipin antibodies in ischemic heart disease: marker or myth? Br Heart J 1993; 69: 391-4.

Raghavan C. , Ditchfield J. , Taylor RJ , Haeney MR , Barnes PC Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction. J Clin Pathol 1993; 46: 1113-15.

Cortellaro M. , Boschetti M. , Cardillo M. , Barbui T. Antiphospholipid antibodies in patients with previous myocardial infarction. Lancet 1992 ; 339:929-30.

Levine SR , Brey RL , Kittner SJ Antiphospholipid antibodies and recurrent thrombo-occlusive events . Lancet 1992; 340: 117.

Rosove MH , Brewer Pmc. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303-8.

Cortelazzo S. , Finazzi G. , Viero P. et al. Thrombotic and haemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemos 1993; 69: 316-20.

Orlando E. , Cortelazzo S. , Marchetti M. , Sanfratello R. , Barbui T. Prolonged bleeding time in patients with lupus anticoagulant. Thromb Haemost 1992; 68: 495-9.

Bajaj SP , Rapaport SI , Fierer DS , Herbst KD , Schwartz DB A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome. Blood 1983; 61: 684-92.

Babikian VL , Levine SR Therapeutic considerations for stroke patients with antiphospholipid antibodies. Stroke 1992 ; 23 (Suppl.I): I-33-I-37.

Lechner K. , Pabinger-Faching I. Lupus anticoagulant and thrombosis. A study of 25 cases and review of the literature. Haemostasis 1985; 15: 254-62.

Singleton D. , Conyers L. Warfarin and azathioprine: an important drug interaction. Am J Med 1992; 92: 217.

Rivier G. , Khamashta MA , Hughes Grv. Warfarin and azathioprine: a drug interaction does exist. Am J Med 1993; 95: 342.

Bern MM , Lokich JJ , Wallach SR et al. Very low doses of warfarin can prevent thrombosis in central vein catheters: a randomized prospective trial. Ann Intern Med 1990; 112: 423-8.

Levine M. , Hirsh J. , Gent M. et al. Double-blind randomised trial of very-low dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 1994; 343: 886-9.

Poller L. , McKeman A. , Thomson JM , Elstein M. , Hirsch PJ , Jones JB Fixed mini-dose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery. Br Med J 1987 ; 70: 343-50.

Antiplatelet Trialist' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106.

Antiplatelet Trialist' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 1994; 308: 235-46.

Exner T. , Triplett DA , Taberner D. , Machin SJ Guidelines for testing and revised criteria for lupus anticoagulants . Thromb Haemost 1991; 65:320-2.